0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monogenic Disease Testing Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-13R12671
Home | Market Reports | Health| Health Conditions
Global Monogenic Disease Testing Market Research Report 2022
BUY CHAPTERS

Global Monogenic Disease Testing Market Research Report 2025

Code: QYRE-Auto-13R12671
Report
March 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Monogenic Disease Testing Market Size

The global market for Monogenic Disease Testing was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 165 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Monogenic Disease Testing Market

Monogenic Disease Testing Market

North American market for Monogenic Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monogenic Disease Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monogenic Disease Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monogenic Disease Testing include Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monogenic Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monogenic Disease Testing.
The Monogenic Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monogenic Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monogenic Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Monogenic Disease Testing Market Report

Report Metric Details
Report Name Monogenic Disease Testing Market
Accounted market size in year US$ 104 million
Forecasted market size in 2031 US$ 165 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Monogenic Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Monogenic Disease Testing Market growing?

Ans: The Monogenic Disease Testing Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Monogenic Disease Testing Market size in 2031?

Ans: The Monogenic Disease Testing Market size in 2031 will be US$ 165 million.

Who are the main players in the Monogenic Disease Testing Market report?

Ans: The main players in the Monogenic Disease Testing Market are Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories

What are the Application segmentation covered in the Monogenic Disease Testing Market report?

Ans: The Applications covered in the Monogenic Disease Testing Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Monogenic Disease Testing Market report?

Ans: The Types covered in the Monogenic Disease Testing Market report are Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive and Pre-Symptomatic Testing, Prenatal Testing

Recommended Reports

Genetic Testing Markets

Gene & Disease Detection

Gene Therapy & Genomics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenic Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive and Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.3 Market by Application
1.3.1 Global Monogenic Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monogenic Disease Testing Market Perspective (2020-2031)
2.2 Global Monogenic Disease Testing Growth Trends by Region
2.2.1 Global Monogenic Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monogenic Disease Testing Historic Market Size by Region (2020-2025)
2.2.3 Monogenic Disease Testing Forecasted Market Size by Region (2026-2031)
2.3 Monogenic Disease Testing Market Dynamics
2.3.1 Monogenic Disease Testing Industry Trends
2.3.2 Monogenic Disease Testing Market Drivers
2.3.3 Monogenic Disease Testing Market Challenges
2.3.4 Monogenic Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monogenic Disease Testing Players by Revenue
3.1.1 Global Top Monogenic Disease Testing Players by Revenue (2020-2025)
3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2020-2025)
3.2 Global Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monogenic Disease Testing Revenue
3.4 Global Monogenic Disease Testing Market Concentration Ratio
3.4.1 Global Monogenic Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenic Disease Testing Revenue in 2024
3.5 Global Key Players of Monogenic Disease Testing Head office and Area Served
3.6 Global Key Players of Monogenic Disease Testing, Product and Application
3.7 Global Key Players of Monogenic Disease Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monogenic Disease Testing Breakdown Data by Type
4.1 Global Monogenic Disease Testing Historic Market Size by Type (2020-2025)
4.2 Global Monogenic Disease Testing Forecasted Market Size by Type (2026-2031)
5 Monogenic Disease Testing Breakdown Data by Application
5.1 Global Monogenic Disease Testing Historic Market Size by Application (2020-2025)
5.2 Global Monogenic Disease Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monogenic Disease Testing Market Size (2020-2031)
6.2 North America Monogenic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monogenic Disease Testing Market Size by Country (2020-2025)
6.4 North America Monogenic Disease Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monogenic Disease Testing Market Size (2020-2031)
7.2 Europe Monogenic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monogenic Disease Testing Market Size by Country (2020-2025)
7.4 Europe Monogenic Disease Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monogenic Disease Testing Market Size (2020-2031)
8.2 Asia-Pacific Monogenic Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monogenic Disease Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Monogenic Disease Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monogenic Disease Testing Market Size (2020-2031)
9.2 Latin America Monogenic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monogenic Disease Testing Market Size by Country (2020-2025)
9.4 Latin America Monogenic Disease Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monogenic Disease Testing Market Size (2020-2031)
10.2 Middle East & Africa Monogenic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monogenic Disease Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Monogenic Disease Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celera Support Services
11.1.1 Celera Support Services Company Details
11.1.2 Celera Support Services Business Overview
11.1.3 Celera Support Services Monogenic Disease Testing Introduction
11.1.4 Celera Support Services Revenue in Monogenic Disease Testing Business (2020-2025)
11.1.5 Celera Support Services Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenic Disease Testing Introduction
11.2.4 Abbott Revenue in Monogenic Disease Testing Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 ELITech Group
11.3.1 ELITech Group Company Details
11.3.2 ELITech Group Business Overview
11.3.3 ELITech Group Monogenic Disease Testing Introduction
11.3.4 ELITech Group Revenue in Monogenic Disease Testing Business (2020-2025)
11.3.5 ELITech Group Recent Development
11.4 Auto Genomics
11.4.1 Auto Genomics Company Details
11.4.2 Auto Genomics Business Overview
11.4.3 Auto Genomics Monogenic Disease Testing Introduction
11.4.4 Auto Genomics Revenue in Monogenic Disease Testing Business (2020-2025)
11.4.5 Auto Genomics Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Details
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Monogenic Disease Testing Introduction
11.5.4 PerkinElmer Revenue in Monogenic Disease Testing Business (2020-2025)
11.5.5 PerkinElmer Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Monogenic Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Carrier Testing
 Table 3. Key Players of Diagnostic Testing
 Table 4. Key Players of New-Born Screening
 Table 5. Key Players of Predictive and Pre-Symptomatic Testing
 Table 6. Key Players of Prenatal Testing
 Table 7. Global Monogenic Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Monogenic Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Monogenic Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Monogenic Disease Testing Market Share by Region (2020-2025)
 Table 11. Global Monogenic Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Monogenic Disease Testing Market Share by Region (2026-2031)
 Table 13. Monogenic Disease Testing Market Trends
 Table 14. Monogenic Disease Testing Market Drivers
 Table 15. Monogenic Disease Testing Market Challenges
 Table 16. Monogenic Disease Testing Market Restraints
 Table 17. Global Monogenic Disease Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Monogenic Disease Testing Market Share by Players (2020-2025)
 Table 19. Global Top Monogenic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2024)
 Table 20. Ranking of Global Top Monogenic Disease Testing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Monogenic Disease Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Monogenic Disease Testing, Headquarters and Area Served
 Table 23. Global Key Players of Monogenic Disease Testing, Product and Application
 Table 24. Global Key Players of Monogenic Disease Testing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Monogenic Disease Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Monogenic Disease Testing Revenue Market Share by Type (2020-2025)
 Table 28. Global Monogenic Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Monogenic Disease Testing Revenue Market Share by Type (2026-2031)
 Table 30. Global Monogenic Disease Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Monogenic Disease Testing Revenue Market Share by Application (2020-2025)
 Table 32. Global Monogenic Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Monogenic Disease Testing Revenue Market Share by Application (2026-2031)
 Table 34. North America Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Monogenic Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Monogenic Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Monogenic Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Monogenic Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Monogenic Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Monogenic Disease Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Monogenic Disease Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Monogenic Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Monogenic Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Monogenic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Monogenic Disease Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Monogenic Disease Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Celera Support Services Company Details
 Table 50. Celera Support Services Business Overview
 Table 51. Celera Support Services Monogenic Disease Testing Product
 Table 52. Celera Support Services Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 53. Celera Support Services Recent Development
 Table 54. Abbott Company Details
 Table 55. Abbott Business Overview
 Table 56. Abbott Monogenic Disease Testing Product
 Table 57. Abbott Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 58. Abbott Recent Development
 Table 59. ELITech Group Company Details
 Table 60. ELITech Group Business Overview
 Table 61. ELITech Group Monogenic Disease Testing Product
 Table 62. ELITech Group Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 63. ELITech Group Recent Development
 Table 64. Auto Genomics Company Details
 Table 65. Auto Genomics Business Overview
 Table 66. Auto Genomics Monogenic Disease Testing Product
 Table 67. Auto Genomics Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 68. Auto Genomics Recent Development
 Table 69. PerkinElmer Company Details
 Table 70. PerkinElmer Business Overview
 Table 71. PerkinElmer Monogenic Disease Testing Product
 Table 72. PerkinElmer Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 73. PerkinElmer Recent Development
 Table 74. Bio-Rad Laboratories Company Details
 Table 75. Bio-Rad Laboratories Business Overview
 Table 76. Bio-Rad Laboratories Monogenic Disease Testing Product
 Table 77. Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2020-2025) & (US$ Million)
 Table 78. Bio-Rad Laboratories Recent Development
 Table 79. Research Programs/Design for This Report
 Table 80. Key Data Information from Secondary Sources
 Table 81. Key Data Information from Primary Sources
 Table 82. Authors List of This Report


List of Figures
 Figure 1. Monogenic Disease Testing Picture
 Figure 2. Global Monogenic Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Monogenic Disease Testing Market Share by Type: 2024 VS 2031
 Figure 4. Carrier Testing Features
 Figure 5. Diagnostic Testing Features
 Figure 6. New-Born Screening Features
 Figure 7. Predictive and Pre-Symptomatic Testing Features
 Figure 8. Prenatal Testing Features
 Figure 9. Global Monogenic Disease Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Monogenic Disease Testing Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Others Case Studies
 Figure 14. Monogenic Disease Testing Report Years Considered
 Figure 15. Global Monogenic Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Monogenic Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Monogenic Disease Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Monogenic Disease Testing Market Share by Players in 2024
 Figure 19. Global Top Monogenic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Monogenic Disease Testing Revenue in 2024
 Figure 21. North America Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Monogenic Disease Testing Market Share by Country (2020-2031)
 Figure 23. United States Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Monogenic Disease Testing Market Share by Country (2020-2031)
 Figure 27. Germany Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Monogenic Disease Testing Market Share by Region (2020-2031)
 Figure 35. China Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Monogenic Disease Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Monogenic Disease Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Monogenic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Celera Support Services Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 51. Abbott Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 52. ELITech Group Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 53. Auto Genomics Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 54. PerkinElmer Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Monogenic Disease Testing Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart